About IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia
During the past decade, IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia"
#1 collaborator was "ERIC Group" with 1 trials as a collaborator and "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia
According to Clinical.Site data, the most researched conditions in "IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia" are
"Hodgkin Lymphoma" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Mantle Cell Lymphoma" (2 trials), "Acute Lymphoid Leukemia" (1 trials) and "Acute Myeloid Leukemia With FLT3/ITD Mutation" (1 trials). Many other conditions were trialed in "IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia" in a lesser frequency.
Clinical Trials Intervention Types at IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia
Most popular intervention types in "IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia" are "Drug" (13 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Venetoclax" (2 trials), "Bleomycin" (1 trials), "Brentuximab Vedotin" (1 trials), "Carfilzomib" (1 trials) and "Chemotherapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia
The vast majority of trials in "IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia" are
16 trials for "All" genders.
Clinical Trials Status at IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia
Currently, there are NaN active trials in "IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia".
1 are not yet recruiting,
7 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".